Scientific Reports (Jan 2021)

Longitudinal saliva omics responses to immune perturbation: a case study

  • George I. Mias,
  • Vikas Vikram Singh,
  • Lavida R. K. Rogers,
  • Shuyue Xue,
  • Minzhang Zheng,
  • Sergii Domanskyi,
  • Masamitsu Kanada,
  • Carlo Piermarocchi,
  • Jin He

DOI
https://doi.org/10.1038/s41598-020-80605-6
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 20

Abstract

Read online

Abstract Saliva omics has immense potential for non-invasive diagnostics, including monitoring very young or elderly populations, or individuals in remote locations. In this study, multiple saliva omics from an individual were monitored over three periods (100 timepoints) involving: (1) hourly sampling over 24 h without intervention, (2) hourly sampling over 24 h including immune system activation using the standard 23-valent pneumococcal polysaccharide vaccine, (3) daily sampling for 33 days profiling the post-vaccination response. At each timepoint total saliva transcriptome and proteome, and small RNA from salivary extracellular vesicles were profiled, including mRNA, miRNA, piRNA and bacterial RNA. The two 24-h periods were used in a paired analysis to remove daily variation and reveal vaccination responses. Over 18,000 omics longitudinal series had statistically significant temporal trends compared to a healthy baseline. Various immune response and regulation pathways were activated following vaccination, including interferon and cytokine signaling, and MHC antigen presentation. Immune response timeframes were concordant with innate and adaptive immunity development, and coincided with vaccination and reported fever. Overall, mRNA results appeared more specific and sensitive (timewise) to vaccination compared to other omics. The results suggest saliva omics can be consistently assessed for non-invasive personalized monitoring and immune response diagnostics.